MuzMp3indir.Net

Tmp8 Rrmm Mp3 indir dur

tmp8 RrMM
Süre: 0:10 | Boyut: 390.63 kB

OPTIMISMM Trial: Pomalidomide in RRMM
Süre: 3:04 | Boyut: 7.02 MB

Ixazomib, Pomalidomide and Dexamethasone (IxPd) in RRMM characterized with high-risk cytogenetics
Süre: 7:43 | Boyut: 17.66 MB

Update on CARTITUDE-1: CAR-T in RRMM
Süre: 4:10 | Boyut: 9.54 MB

Treatment Options in RRMM
Süre: 3:06 | Boyut: 7.1 MB

Tocilizumab pre-treatment reduced cytokine release syndrome in RRMM pts receiving cevostamab.
Süre: 10:29 | Boyut: 23.99 MB

MajesTEC-2 update: teclistamab plus lenalidomide in R/R multiple myeloma
Süre: 0:45 | Boyut: 1.72 MB

EVOLVE: Orva-cel in RRMM
Süre: 7:26 | Boyut: 17.01 MB

Quality of life in pts with RRMM treated with pomalidamide and dex ± subcutaneous dara: APOLLO
Süre: 5:31 | Boyut: 12.63 MB

MonumenTAL-1: talquetamab in R/R multiple myeloma
Süre: 10:11 | Boyut: 23.31 MB

Elranatamab in Combination with Daratumumab for Pts with RRMM: Phase 3 MagnetisMM-5
Süre: 9:07 | Boyut: 20.87 MB

Phase 3, open-label, randomized trial comparing belamaf to Pd in RRMM: DREAMM-3 study
Süre: 10:43 | Boyut: 24.53 MB

Iberdomide with cyclophosphamide and dexamethasone in RRMM: first results from the ICON study
Süre: 2:02 | Boyut: 4.65 MB

Post-authorization study of pomalidomide in R/R multiple myeloma with prior triple class exposure
Süre: 1:25 | Boyut: 3.24 MB

The value of teclistamab in R/R myeloma & strategies to mitigate toxicities
Süre: 1:45 | Boyut: 4.01 MB

TRIMM-2: talquetamab + daratumumab in patients with R/R multiple myeloma
Süre: 1:44 | Boyut: 3.97 MB

MuzMp3indir.Net | About